(Q45254370)

11 December 2017

title

Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study (English)

1 reference

11 December 2017

1 reference

1 reference

Sue Zhang

1

1 reference

11 December 2017

Jessica T Ristau

2

1 reference

11 December 2017

Huy N Trinh

3

1 reference

11 December 2017

Ruel T Garcia

4

1 reference

11 December 2017

Huy A Nguyen

5

1 reference

11 December 2017

Mindie H Nguyen

6

1 reference

11 December 2017

publication date

31 March 2012

1 reference

Digestive Diseases and Sciences

11 December 2017

published in

1 reference

11 December 2017

volume

57

1 reference

11 December 2017

issue

5

1 reference

11 December 2017

page(s)

1373-1383

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2137-0

11 December 2017

exact match

0 references

cites work

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Chronic hepatitis B: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Epidemiology and natural history of hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

The prevalence of hepatitis B virus infection in the United States in the era of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Review article: current antiviral therapy of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Is chronic hepatitis B being undertreated in the United States?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Benefits and risks of nucleoside analog therapy for hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: A systematic review of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

The clinical significance of persistently normal ALT in chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Halting the natural history of hepatitis B viral infection: a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

The management of chronic hepatitis B in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2137-0

Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.

1 reference

12 December 2020

1 reference

12 December 2020

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescent

1 reference

12 December 2020

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults

1 reference

12 December 2020

Chronic hepatitis. An update on terminology and reporting.

1 reference

12 December 2020

Screening for chronic hepatitis B among Asian/Pacific Islander populations--New York City, 2005

1 reference

12 December 2020

Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California

1 reference

12 December 2020

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

1 reference

12 December 2020

10.1007/S10620-012-2137-0

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1029896725

0 references

1 reference